Drug Design

Bayer and Iambic Partner to Advance AI-Driven Drug Discovery

Bayer and Iambic Therapeutics are collaborating to research new drugs using Iambic's AI-based platform. The collaboration focuses on the discovery of small molecules.

Topics • Pharma

Aligning Artificial Intelligence and Laboratory Execution in Drug Discovery

From In Silico Design to In Vitro Impact

Top-Feature

Citrine

Operationalizing AI in Polymer Development: How Syensqo Is Scaling Impact with the Citrine Platform

SCIEX

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

CHEManager International c/o Wiley-VCH GmbH

Predictive Simulation in Pharma Production

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Special Issue

Explore the Future of Plastics

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Iktos AI

Bayer AG

Drug Design

Bayer and Iambic Partner to Advance AI-Driven Drug Discovery

Aligning Artificial Intelligence and Laboratory Execution in Drug Discovery

Top-Feature

Operationalizing AI in Polymer Development: How Syensqo Is Scaling Impact with the Citrine Platform

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

Siemens Joins the Global Impact Coalition

Upcoming Virtual Events

Predictive Simulation in Pharma Production

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Special Issue

Circular Plastics Economy

Drug Design

Bayer and Iambic Partner to Advance AI-Driven Drug Discovery

Aligning Artificial Intelligence and Laboratory Execution in Drug Discovery

Top-Feature

Operationalizing AI in Polymer Development: How Syensqo Is Scaling Impact with the Citrine Platform

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

Siemens Joins the Global Impact Coalition

Upcoming Virtual Events

Predictive Simulation in Pharma Production

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Special Issue

Circular Plastics Economy

Newsletter & e-edition